Treace Medical Concepts, Inc.
Treace Medical Concepts, Inc.
Your view on TMCI
Overview
What the company does, where it operates, and who runs it.
About Treace Medical Concepts, Inc.
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- John T. Treace
- Headquarters
- 203 Fort Wade Road, Ponte Vedra, FL, US
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- John T. Treace
- Headquarters
- 203 Fort Wade Road, Ponte Vedra, FL, US
Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States.
It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement. The company also provides Lapiplasty Mini-Incision precision system.
In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, weil osteotomies, intercuneiform stabilization, lesser tarsometatarsal joint fusions, and autograft bone harvesting, as well as for MTP fusion. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra Beach, Florida.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Treace Medical Concepts, Inc., and the rating behind it. TMCI last traded at $4.51; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Treace Medical Concepts, Inc.. Starting points for Treace Medical Concepts, Inc.: EPS -$0.91, beta 1.41 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Treace Medical Concepts, Inc.. Treace Medical Concepts, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Treace Medical Concepts, Inc.. Trailing twelve-month EPS for Treace Medical Concepts, Inc. stands at -$0.91. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Treace Medical Concepts, Inc.. Treace Medical Concepts, Inc. has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Treace Medical Concepts, Inc. valued side by side against its closest peers. Treace Medical Concepts, Inc. is measured against Medical - Devices peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Treace Medical Concepts, Inc., and how their positions are changing. At a $292.6M market value, institutional positions materially move Treace Medical Concepts, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Treace Medical Concepts, Inc. executives and directors. Shares of Treace Medical Concepts, Inc. have traded between $2.71 and $10.79 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Treace Medical Concepts, Inc.. Treace Medical Concepts, Inc. is a $292.6M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Treace Medical Concepts, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Treace Medical Concepts, Inc.. Coverage tracks Treace Medical Concepts, Inc. within Medical - Devices (Healthcare). Press releases and market coverage, newest first.